TrialOncotarget2016

Inflammatory indexes as predictors of prognosis and bevacizumab efficacy in patients with metastatic colorectal cancer.

Alessandro Passardi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.